FRANTECH INTERNATIONAL
FOR IMEDIATE RELEASE

VENTURA, California. January 10, 2006 - Nutrition By Nanotech, LLC (Nutrition By Nanotech) signed a non-exclusive agreement with FranTech International Licensing, Inc. (FranTech), of Ventura, California, which grants FranTech the right to market Nutrition By Nanotech's Nanoceutical™ Delivery System through FranTech's network of agents in 220 countries to governments around the world.     

TThe company explained that the Nutrition By Nanotech's Nanoceutical™ Delivery System are uniquely suited to meet the needs of most countries. This proprietary system disperses active molecules of dietary supplements into Nanodroplets that dramatically increase the bioavailability of nutrients into the body.  

J. Michael Valo, President of Nutrition By Nanotech, said, "We chose FranTech because of their tremendous geographic reach and proven track record in establishing licensing agreements. With more than 35 years of experience, FranTech knows international trade policy, law, marketing, investment banking, and technology research. Their broad expertise, coupled with access to key governmental and healthcare industry decision makers, provides services uniquely valuable to Nutrition By Nanotech overseas." 

The company explained that FranTech's mission is to foster the development of the global economy by providing a global perspective to developers, marketers, manufacturers and innovators on newly emerging and preemptive technologies. They offer world-class solutions for the licensing and transfer of USA innovations to emerging economies.

PPhilip Nadeau, CEO of FranTech, said, "We see a tremendous market worldwide for the Nanoceutical™ Delivery System and already have interest from several countries. We plan on developing brand name recognition and positioning of Nutrition By Nanotech with many governmental agencies for new healthcare development, where we already have relationships in place."

About Nutrition By Nanotech, LLC

Nutrition by Nanotech has developed proprietary healthcare supplements in the form of nano-partical sprays. Currently, Nutrition By Nanotech offers a Vitamin B-12 Booster, Nanoceutical™ Delivery System and a Vitamin B Complex.

TNutrition by Nanotech's proprietary technology utilizes a nano-technology process, which allows molecules to be embedded within nano droplets or 'microdroplets', which are used to create a stable and uniform emulsion and dispersion pattern. This process allows for faster and more effective absorption and stability of the nutrients through the transmucosal membranes and into the circulatory system, than oral digestion of pills or capsules.

About FranTech International Licensing, Inc.

FFranTech consists of core partners surrounded by interlocking networks of consultants and affiliates in key trading countries and disciplines. They have over thirty-five years of experience with their proven partners. In addition, FranTech has proven track records in assembling, negotiating and consummating trade, licensing, technological and financial agreements; they pool strengths drawn from experience in international trade policy, law, marketing, investment banking and technology research. This broad expertise, coupled with access to key governmental and business decision makers, provides services uniquely valuable to Nutrition By Nanotech in the restructuring global economy. Nutrition By Nanotech is pleased to commence a strong working relationship with FranTech.

FranTech's mission is to foster the development of the global economy by providing a global perspective to developers, marketers, manufactures, and innovators of newly emerging and preemptive technologies. They offer world-class solutions for the licensing and transfer of USA and worldwide innovations to emerging economies in 220 countries worldwide for over thirty-five years. 

For information on this exclusive technology  

Contact:

David Baker, President

http://www.FranTechUSA.com

Safe Harbor Statment:  Statements in this press release that are not statements of historical or current fact constitute "foreward-looking statements" withini the meaning of the Private Securities Litigation Reform Act of 1995. Such foreward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the actual results of the Company to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements.  In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider stratements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will" or "plans" to be uncertain nad forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports and registration statements filed with the Securities and Exchange Commission.